We are live on ! Find out more
DMTK

DermTech, Inc. Common Stock
DMTK

Delisted

DMTK was delisted on the 26th of June, 2024.

Back to rankings

19 hedge funds and large institutions have $89.1M invested in DermTech, Inc. Common Stock in 2017 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 6 increasing their positions, 2 reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 2

58% more funds holding

Funds holding: 12 → 19 (+7)

43% more capital invested

Capital invested by funds: $62.1M → $89.1M (+$27M)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

Holders
19
Holders Change
+7
Holders Change %
+58.33%
% of All Funds
0.43%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
7
Increased
6
Reduced
2
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BFM
Boothbay Fund Management
New York
+$11.2M
2
OAM
Oxford Asset Management
United Kingdom
+$8.59M
3
LIM
Longfellow Investment Management
Massachusetts
+$3.84M
4
YCM
Yakira Capital Management
Connecticut
+$1.46M
5
WAM
Weiss Asset Management
Massachusetts
+$1.21M

Top Sellers

Rank Fund Capital Flow
1
CI
Cowen Inc
New York
-$2.44M
2
AA
AQR Arbitrage
Connecticut
-$492K

DMTK Hedge Fund Activity: Q4 2017 in Review

19 of the 4,419 institutional investors tracked by Wall St. Rank reported a position in DermTech, Inc. Common Stock (DMTK) for Q4 2017, worth a combined $89.1M — up 43% from $62.1M a quarter earlier.

Buyers outnumbered sellers: 7 funds opened new DMTK positions and 0 closed out — a net gain of 7 holders — while 6 added to existing stakes and 2 trimmed.

The largest buyer was Boothbay Fund Management, opening a new position worth an estimated $11.2M. The largest seller was Cowen Inc, cutting an estimated $2.44M.

  • 19 institutional investors held DermTech, Inc. Common Stock (DMTK) as of Q4 2017, up from 12 in Q3 2017.
  • Funds reported $89.1M of DermTech, Inc. Common Stock stock for Q4 2017, up 43% quarter-over-quarter.
  • 7 funds opened new DermTech, Inc. Common Stock positions in Q4 2017 and 0 closed out, a net change of +7 holders.
  • The largest DermTech, Inc. Common Stock buyer in Q4 2017 was Boothbay Fund Management, an estimated $11.2M added.
  • The largest DermTech, Inc. Common Stock seller in Q4 2017 was Cowen Inc, an estimated $2.44M sold.

Based on aggregated 13F filings for Q4 2017.